This system distinguishes different subtypes of low‐ and of high‐grade glioma based on mutations in isocitrate dehydrogenase 1 (IDH1), and codeletion of the short arm of chromosome 1 and the long arm of chromosome 19 (1q/19p) (Sanson et al., 2009). The gene discussed is IDH1; the disease is central nervous system cancer.